- Home
- AIRI vs SCNX Comparison
AIRI vs SCNX Comparison
Compare AIRI & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRI | SCNX |
|---|---|---|
| Founded | 1979 | 2010 |
| Country | United States | United States |
| Employees | N/A | 19 |
| Industry | Military/Government/Technical | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 19.0M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRI | SCNX |
|---|---|---|
| Price | $3.21 | $0.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 146.5K | ★ 2.1M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,108,000.00 | N/A |
| Revenue This Year | N/A | $347.88 |
| Revenue Next Year | $3.53 | $744.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.97 | N/A |
| 52 Week Low | $2.55 | $0.37 |
| 52 Week High | $4.17 | $3.17 |
Technical Indicators
Market Signals| Indicator | AIRI | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 56.24 |
| Support Level | $3.18 | $0.47 |
| Resistance Level | $3.38 | $0.60 |
| Average True Range (ATR) | 0.15 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 21.03 | 54.71 |
Price Performance
Historical ComparisonAbout AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.